Filing Details
- Accession Number:
- 0001209191-17-046035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 21:45:59
- Reporting Period:
- 2017-07-20
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 21:45:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
873303 | Sarepta Therapeutics Inc. | SRPT | Pharmaceutical Preparations (2834) | 930797222 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1685994 | Alexander Cumbo | 215 First Street Suite 415 Cambridge MA 02142 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-20 | 2,500 | $13.71 | 22,793 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-07-20 | 2,500 | $41.00 | 20,293 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-20 | 3,418 | $41.00 | 16,875 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2017-07-20 | 2,500 | $13.71 | 2,500 | $13.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,774 | 2017-02-28 | 2026-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 15, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.